On The Fly
|
Check out this evening's… ShowHide Related Items >><< - $409.67 /
+35.805 (+9.58%) - 03/01/21
- Zoom Video jumps 8% to $444.10 after Q4 results, FY22 guidance beat estimates
- 03/01/21
- Lumen announces launch of Zoom Phone
- 02/03/21
- Zoom Video announces availability of Zoom Rooms innovations
- 01/26/21
- User reports indicate Zoom Video experiencing issues, says DownDetector
- 03/01/21
- TTEC Holdings raises semi-annual dividend by 7.5% to 43c per share
- 01/21/21
- TTEC Holdings partners with Schwan's Home Delivery
- 12/03/20
- TTEC Holdings declares special, one-time cash dividend of $2.14 per share
- 09/28/20
- TTEC Holdings increases semi-annual cash dividend to 40c per share
- 03/01/21
- TransMedics announces scheduling of OCS Heart FDA AdCom meeting
- 09/28/20
- FDA postpones advisory committee meeting to review TransMedics OCS Heart
- 03/01/21
- Switch drops about 7% to $16.51 after reporting mixed Q4 results
- 09/16/20
- Switch appoints Angela Archon to Board of Directors, effective November 4
- 02/25/21
- Sarepta rallies 2% to $86.15 after winning FDA approval for DMD treatment
- 02/25/21
- Sarepta announces FDA approval of Amondys 45
- 02/08/21
- Dyne Therapeutics appoints Ashish Dugar as SVP, global head of medical affairs
- 01/13/21
- Sarepta, Genevant announce collaboration for gene editing therapeutics
- 02/25/21
- Silk Road Medical publishes study on TCAR availability and MACE
- 02/04/21
- Silk Road Medical 'isolated the root cause' related to stent recall
- 01/25/21
- Silk Road Medical voluntarily recalling additional lots of Enroute system
- 01/13/21
- Silk Road Medical reports voluntarily recall of ENROUTE SDS units
- 03/01/21
- Scientific Games drops 5% to $48.00 after reporting Q4 results
- 03/01/21
- International Game, Scientific Games sign cross-licensing agreement
- 12/10/20
- Scientific Games to supply lottery games for SISAL in Morocco
- 12/01/20
- Scientific Games partners with Genius Sports Group
- 09/23/20
- SciPlay appoints Danny Moy as Chief Strategy Officer
- $420.23 /
+25.095 (+6.35%) - 03/01/21
- Roku to acquire Nielsen's video advertising business
- 02/18/21
- Roku CEO says FY21 revenue growth to fall below levels of Q1 and Q2
- 02/18/21
- Roku reports Q4 Active accounts 51.2M vs. 36.9M last year
- 01/21/21
- Cinedigm launches All3Media's streaming channel SO... REAL App on Roku
- 02/23/21
- RedHill Biopharma to expand opaganib global Phase 2/3 COVID-19 study
- 01/29/21
- RedHill Biopharma announces independent DSMB recommendation for opaganib
- 01/06/21
- RedHill Biopharma's RHB-204 granted FDA Fast Track designation for NTM disease
- 12/31/20
- RedHill Biopharma announces safety, efficacy data from Phase 2 COVID-19 study
- 01/29/21
- OraSure's OM-505 saliva collection kit included in EUA granted to Ambry
- 01/28/21
- OraSure's saliva collection device authorized by Health Canada for COVID-19 test
- 01/26/21
- Chronomics selects OraSure's OMNIgene ORAL salive collection kit
- 01/21/21
- OraSure's saliva collection kit Included in FDA authorization for exome platform
- 02/26/21
- Novavax, Takeda finalize license agreement for COVID-19 vaccine in Japan
- 02/24/21
- Takeda provides update on Novavax, Moderna COVID-19 vaccine candidates in Japan
- 02/22/21
- House committee posts remarks from Pfizer, Moderna, J&J execs ahead of testimony
- 02/22/21
- Novavax completes enrollment of PREVENT-19 Phase 3 trial
- 02/25/21
- Twitter exploring 'super follows,' users able to subscribe for exclusive content
- 02/16/21
- Elliott buys Evergy, exits eBay in Q4
- 01/12/21
- Nielsen begins tracking premium theatrical films distributed via streaming
- 02/01/21
- NIO delivers 7,225 vehicles in January, up 352.1%
- 01/10/21
- Fly Intel: Top five weekend stock stories
- 01/10/21
- Nio partners with Nvidia to develop new generation of automated driving EV
- 01/03/21
- NIO Inc. reports 7,007 vehicle deliveries in December 2020
- 03/01/21
- Point72 Asset Management reports 6.4% passive stake in Mereo BioPharma
- 12/17/20
- Ultragenyx, Mereo BioPharma announce setrusumab license agreement
- 12/15/20
- Mereo BioPharma provides update on continued listing of ADSs on Nasdaq
- 11/23/20
- Mereo BioPharma appoints Suba Krishnan as SVP, clinical development
- $84.57 /
+48.64 (+135.37%) - 03/01/21
- Morphic Holding Inc trading resumes
- 03/01/21
- Morphic Holding Inc trading halted, volatility trading pause
- 03/01/21
- Morphic Holding reports interim results from Phase 1 trial of MORF-057
- 01/05/21
- Morphic Therapeutic expands R&D collaboration with Janssen
- $1,715.90 /
+80.81 (+4.94%) - 02/16/21
- Lone Pine bought Snap and Carvana during Q4, exited PayPal
- 01/07/21
- MercadoLibre announces repurchase of $440M convertible senior notes
- 11/24/20
- Amazon Web Services selected by MercadoLibre as primary cloud provider
- 01/21/21
- Lemonade director sells 65.5K shares of common stock
- 01/14/21
- Lemonade falls -4.9%
- 01/12/21
- Lemonade falls -6.0%
- 12/31/20
- Lemonade reports over 1M active customers at end of 2020
- 02/24/21
- Inseego to sell Ctrack South Africa operations for $36.2M
- 03/01/21
- Inovio reports REVEAL 1 trial met primary, secondary endpoints
- 02/24/21
- Qiagen, Inovio expand collaboration to develop NGS companion diagnostic
- 02/23/21
- Inovio doses first patient in Phase 1B clinical trial for INO-4500
- 01/06/21
- Inovio reports positive efficacy results from Phase 2 trial of VGX-3100
- 01/21/21
- Helios Technologies to acquire BJN Technologies, terms undisclosed
- 10/12/20
- Helios Technologies to acquire Balboa Water Group for $218.5M
- 03/01/21
- FibroGen, AstraZeneca report FDA to hold AdCom meeting to review roxadustat NDA
- 12/22/20
- FibroGen doses first patient in ZEPHYRUS-2 Phase 3 study of pamrevlumab
- 12/19/20
- AstraZeneca updates on U.S. regulatory review of roxadustat
- 12/18/20
- FibroGen says FDA extends review period for roxadustat NDA
- 12/07/20
- Cohu CEO Luis Muller sells over $1M in company shares
- 02/25/21
- Beyond Meat says currently in 'solid liquidity position'
- 02/25/21
- Beyond Meat says proceeding with 'aggressive investment agenda' in 2021
- 02/25/21
- Beyond Meat says seeing 'great growth' in household penetration
- 02/25/21
- Beyond Meat says 'not prepared to elaborate' on new partnerships
ASLN Aslan Pharmaceuticals - 03/01/21
- Aslan Pharmaceuticals reports 'positive' results from study of ASLAN004
- 02/18/21
- Aslan Pharmaceuticals appoints Neil Graham to board of directors
- 01/26/21
- Aslan Pharma's ASLAN003 shows potential for best-in-class DHODH inhibitor
- 10/22/20
- Aslan Pharmaceuticals initiates third dose cohort of ASLAN004
- $160.72 /
-4.985 (-3.01%) - 09/08/20
- AppFolio sells MyCase to Apax Partners fund for $193M
- 02/17/21
- Ameresco in ESA pact with Nyack Public School District for phase ll renovations
- 02/05/21
- Ameresco partners with Navy for $173M energy project at Norfolk Naval Shipyard
- 02/02/21
- Ameresco, Wells Fargo announce collaboration to develop solar generation assets
- 11/25/20
- Ameresco CEO sells 46.3K shares of common stock
- 02/25/21
- C3.ai awarded omnibus U.S. patent for end-to-end enterprise AI platform
- 02/01/21
- Shell, C3, Baker Hughes, Microsoft launch Open AI Energy Initiative
- 12/31/20
- C3.ai falls -5.9%
- 12/30/20
- C3.ai rises 5.6%
- 02/11/21 Oppenheimer
- Opco starts DNA medicines 'disruptor' Inovio with buy, $35 price target
- 02/11/21 Oppenheimer
- Inovio initiated with an Outperform at Oppenheimer
- 02/09/21 Maxim
- Heat data puts cancer vaccine discussion 'back on the table,' says Maxim
- 01/08/21 Benchmark
- Inovio price target lowered to $15 from $25 at Benchmark
ASLN Aslan Pharmaceuticals - 03/01/21 Piper Sandler
- Piper boosts Aslan target to $10 after positive atopic dematitis data
- 04/13/20 Piper Sandler
- Aslan interim data for ASLN004 study still expected in 2020, says Piper Sandler
- 03/18/20 Piper Sandler
- Aslan Pharmaceuticals price target lowered to $6 from $8 at Piper Sandler
- 12/17/20 Canaccord
- TTEC Holdings price target raised to $90 from $77 at Canaccord
- 10/15/20 Canaccord
- TTEC Holdings model steadily shifts to digital, Canaccord starts with a Buy
- 10/15/20 Canaccord
- TTEC Holdings initiated with a Buy at Canaccord
- 08/10/20
- Fly Intel: Top five analyst downgrades
- $409.67 /
+35.805 (+9.58%) - 01/26/21 MKM Partners
- Fiverr downgraded to Sell from Neutral at MKM Partners
- 01/13/21 Stifel
- Stifel says Zoom growth with Phone reminder of 'powerful' enterprise opportunity
- 01/13/21 Morgan Stanley
- Investors have turned too negative on Zoom's persistence, says Morgan Stanley
- 12/24/20 DA Davidson
- DA Davidson likes Zoom push into email, says buy on recent selloff
- 10/12/20 Baird
- Helios Technologies upgraded to Outperform from Neutral at Baird
- 05/29/20 Morgan Stanley
- Morgan Stanley upgrades Helios to Equal Weight following underperformance
- 05/29/20 Morgan Stanley
- Helios Technologies upgraded to Equal Weight from Underweight at Morgan Stanley
- 03/27/20 Truist
- Helios Technologies price target lowered to $36 from $45 at SunTrust
- 02/09/21 B. Riley Securities
- Ameresco price target raised to $72 from $50 at B. Riley Securities
- 01/26/21 Craig-Hallum
- Ameresco price target raised to $75 from $50 at Craig-Hallum
- 11/03/20 Craig-Hallum
- Ameresco price target raised to $50 from $38 at Craig-Hallum
- 11/03/20 B. Riley Securities
- Ameresco price target raised to $50 from $48 at B. Riley Securities
- 02/24/21 Cowen
- TransMedics price target raised to $44 from $20 at Cowen
- 10/08/20
- Fly Intel: Top five analyst downgrades
- 10/08/20 JPMorgan
- TransMedics downgraded to Neutral on 'missed' execution at JPMorgan
- 10/08/20 JPMorgan
- TransMedics downgraded to Neutral from Overweight at JPMorgan
- $420.23 /
+25.095 (+6.35%) - 02/22/21 Needham
- Roku price target raised to $550 from $400 at Needham
- 02/19/21 Truist
- Roku price target raised to $480 from $390 at Truist
- 02/19/21 JPMorgan
- Roku price target raised to $525 from $475 at JPMorgan
- 02/19/21 Oppenheimer
- Roku price target raised to $500 from $260 at Oppenheimer
- 03/01/21 Truist
- Nielsen price target raised to $26 from $20 at Truist
- 01/28/21 Citi
- Nielsen price target raised to $27 from $22 at Citi
- 11/03/20 Deutsche Bank
- Nielsen price target lowered to $18 from $22 at Deutsche Bank
- 08/25/20 Truist
- Nielsen price target lowered to $20 from $23 at Truist
- 02/01/21 H.C. Wainwright
- FibroGen initiated with a Buy at H.C. Wainwright
- 12/21/20 Mizuho
- FibroGen should be bought on PDUFA extension weakness, says Mizuho
- 10/26/20 Raymond James
- FibroGen initiated with an Underperform at Raymond James
- 10/26/20 Raymond James
- FibroGen initiated with an Underperform at Raymond James
- 01/04/21 KeyBanc
- C3.ai initiated with a Sector Weight at KeyBanc
- 01/04/21 Wedbush
- Wedbush bullish on C3.ai, initiates with an Outperform
- 01/04/21 Canaccord
- C3.ai initiated with a Hold at Canaccord
- 01/04/21 Morgan Stanley
- C3.ai initiated with an Underweight at Morgan Stanley
- 02/17/21 Cowen
- Inseego price target raised to $20 from $17 at Cowen
- 09/04/20 Stifel
- Inseego 5G opportunity highlighted in meetings with management, says Stifel
- 08/06/20
- Fly Intel: Top five analyst downgrades
- 08/06/20 Lake Street
- Inseego price target raised to $17 from $13 at Lake Street
- 01/21/21 Piper Sandler
- Lemonade price target raised to $163 from $105 at Piper Sandler
- 11/23/20 Morgan Stanley
- Root initiated with an Equal Weight at Morgan Stanley
- 11/12/20 Piper Sandler
- Lemonade price target raised to $71 from $63 at Piper Sandler
- 11/02/20 Piper Sandler
- Lemonade initiated with an Overweight at Piper Sandler
- $84.57 /
+48.64 (+135.37%) - 03/01/21 Wells Fargo
- Morphic Holding price target raised to $103 from $40 at Wells Fargo
- 02/02/21 RBC Capital
- Morphic Holding price target raised to $50 from $35 at RBC Capital
- 10/26/20 RBC Capital
- Morphic Holding initiated with an Outperform at RBC Capital
- 08/11/20 BMO Capital
- Morphic Holding price target raised to $37 from $30 at BMO Capital
- 02/18/21 Deutsche Bank
- SciPlay price target raised to $23 from $20 at Deutsche Bank
- 02/17/21 BofA
- SciPlay double-downgraded to Underperform from Buy at BofA
- 12/22/20 Morgan Stanley
- SciPlay price target raised to $16 from $15 at Morgan Stanley
- 12/16/20 JPMorgan
- SciPlay downgraded to Neutral on tough comps at JPMorgan
- 02/26/21 HSBC
- NIO price target raised to $54 from $44.70 at HSBC
- 02/09/21 Deutsche Bank
- NIO job post shows ambitions to enter U.S. market, says Deutsche Bank
- 01/28/21 Morgan Stanley
- NIO price target raised to $80 from $33 at Morgan Stanley
- 01/22/21
- Fly Intel: Top five analyst initiations
- 02/02/21
- Truist sees Switch positioned for long-term growth, starts at Buy
- 02/02/21 Truist
- Switch initiated with a Buy at Truist
- 01/13/21 Jefferies
- Switch upgraded to Buy on earnings growth inflection at Jefferies
- 01/13/21 Jefferies
- Switch upgraded to Buy from Hold at Jefferies
- 02/23/21 B. Riley Securities
- B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
- 02/22/21 Cantor Fitzgerald
- Cantor says PREVENT-19 gives Novavax potential for differentiated analyses
- 02/22/21 B. Riley Securities
- B. Riley reiterates Buy rating on Novavax as PREVENT-19 enrollment wraps up
- 02/18/21 B. Riley Securities
- Novavax price target raised to $397 from $334 at B. Riley Securities
- 02/26/21 Mizuho
- Sarepta price target raised to $160 from $158 at Mizuho
- 02/25/21 Piper Sandler
- Piper says Sarepta's Amondys 45 approval comes with 'relatively clean label'
- 02/09/21 Morgan Stanley
- Sarepta denied motion to dismiss 'Wilson Wolf' case, says Morgan Stanley
- 01/12/21 Citi
- Sarepta downgraded to Neutral from Buy at Citi
- 02/04/21 Piper Sandler
- Silk Road recall update 'should be received positively,' says Piper Sandler
- 01/25/21 Piper Sandler
- Silk Road Medical recall primarily manufacturing related, says Piper Sandler
- 01/13/21 Piper Sandler
- Piper Sandler sees no 'larger issue in play' following Silk Road Medical recall
- 11/11/20 Piper Sandler
- Silk Road Medical price target raised to $58 from $54 at Piper Sandler
- 12/22/20 Lake Street
- Lake Street says OraSure test news disappointing, not due to fundamental issues
- 08/21/20
- Fly Intel: Top five analyst initiations
- 08/21/20 Evercore ISI
- OraSure initiated with an Outperform at Evercore ISI
- 08/21/20 Evercore ISI
- OraSure initiated with an Outperform at Evercore ISI
- $160.72 /
-4.985 (-3.01%) - 02/25/21 DA Davidson
- AppFolio price target raised to $126 from $110 at DA Davidson
- 01/25/21 Stephens
- AppFolio initiated with an Underweight at Stephens
- 01/25/21 Stephens
- AppFolio initiated with an Underweight at Stephens
- 10/26/20 Keefe Bruyette
- AppFolio initiated with a Market Perform at Keefe Bruyette
- 02/09/21 Craig-Hallum
- Scientific Games Digital segment still 'underappreciated,' says Craig-Hallum
- 01/19/21 Jefferies
- Scientific Games price target raised to $55 from $50 at Jefferies
- 01/14/21 Truist
- Scientific Games price target raised to $60 from $45 at Truist
- 01/14/21 Craig-Hallum
- Dec. NJ gaming data caps off year of significant growth, says Craig-Hallum
- $1,715.90 /
+80.81 (+4.94%) - 03/01/21 Credit Suisse
- MercadoLibre price target raised to $1,925 from $1,555 at Credit Suisse
- 02/11/21
- Fly Intel: Top five analyst initiations
- 02/11/21 Scotiabank
- Scotiabank starts MercadoLibre at neutral, awaits better entry point
- 02/11/21 Scotiabank
- MercadoLibre initiated with a Sector Perform at Scotiabank
- 11/12/20 Roth Capital
- RedHill Biopharma price target lowered to $12 from $16 at Roth Capital
- 09/11/20 BTIG
- RedHill Biopharma initiated with a Buy at BTIG
- 08/14/20 Roth Capital
- Roth Capital maintains Buy on RedHill after 'noisy' quarter
- 07/07/20 SMBC Nikko
- RedHill Biopharma initiated with an Outperform at SMBC Nikko
- 02/12/21 Craig-Hallum
- Cohu price target raised to $73 from $45 at Craig-Hallum
- 02/12/21 B. Riley Securities
- Cohu price target raised to $72 from $60 at B. Riley Securities
- 02/10/21 B. Riley Securities
- B. Riley Securities sees interesting opportunities in Skyworks, Silicon Motion
- 01/25/21 B. Riley Securities
- Cohu price target raised to $60 from $46 at B. Riley Securities
- 03/01/21 DA Davidson
- Beyond Meat price target raised to $145 from $133 at DA Davidson
- 02/26/21 Piper Sandler
- Beyond Meat relationship with McDonald's not much changed, says Piper Sandler
- 02/26/21 UBS
- Beyond Meat price target raised to $130 from $107 at UBS
- 02/26/21 Goldman Sachs
- Beyond Meat price target raised to $112 from $105 at Goldman Sachs
- $409.67 /
+35.805 (+9.58%) - 03/01/21
- Zoom Video sees FY22 EPS $3.59-$3.65, consensus $2.96
- 03/01/21
- Zoom Video sees Q1 EPS 95c-97c, consensus 72c
- 03/01/21
- Zoom Video reports Q4 EPS $1.22, consensus 79c
- 03/01/21
- Notable companies reporting after market close
- 03/01/21
- TTEC Holdings sees FY21 EPS $4.06-$4.25, consensus $2.96
- 03/01/21
- TTEC Holdings reports Q4 EPS $1.22, consensus 71c
- 11/04/20
- TTEC Holdings raises FY20 EPS view to $2.92-$3.02 from $2.37-$2.43
- 11/04/20
- TTEC Holdings reports Q3 adjusted EPS 90c, consensus 54c
- 11/04/20
- TransMedics reports Q3 EPS (19c), consensus (32c).
- 03/01/21
- Switch sees FY21 revenue $540M-$555M, consensus $588.3M
- 03/01/21
- Switch reports Q4 adjusted EPS 6c, consensus 5c
- 11/05/20
- Switch sees FY20 revenue $510M-$518M, consensus $516.47M
- 11/05/20
- Switch reports Q3 EPS 5c, consensus 4c
- 03/01/21
- Sarepta reports Q4 EPS ($1.84), consensus ($1.77)
- 03/01/21
- Sarepta reports Q4 EPS ($1.84), consensus ($1.77)
- 11/05/20
- Sarepta reports Q3 EPS ($2.50), consensus ($1.71)
- 03/01/21
- Silk Road Medical sees FY21 revenue $102M-$108M, consensus $111.52M
- 03/01/21
- Silk Road Medical reports Q4 EPS (49c), consensus (28c)
- 11/10/20
- Silk Road Medical reports Q3 EPS (31c), consensus (28c)
- 03/01/21
- Scientific Games reports Q4 EPS (95c), consensus (47c)
- 11/04/20
- Scientific Games reports Q3 EPS ($1.23), consensus (77c)
- 11/04/20
- Scientific Games reports Q3 EPS ($1.23), consensus (77c)
- 11/04/20
- Notable companies reporting after market close
- 03/01/21
- SciPlay reports Q4 EPS 18c, consensus 26c
- 11/04/20
- SciPlay reports Q3 EPS 23c, consensus 25c
- $420.23 /
+25.095 (+6.35%) - 02/18/21
- Roku sees Q1 revenue $478M-$493M, consensus $462.97M
- 02/18/21
- Roku reports Q4 EPS 49c, consensus (5c)
- 02/18/21
- Notable companies reporting after market close
- 11/05/20
- Roku reports Q3 EPS 9c, consensus (40c)
- 11/12/20
- RedHill Biopharma reports Q3 EPS (5c), consenus (16c)
- 03/01/21
- OraSure reports Q4 EPS 3c, consensus 7c
- 11/04/20
- OraSure reports Q EPS 1c, consensus (7c)
- 03/01/21
- Novavax reports Q4 EPS ($2.70), consensus ($1.49)
- 11/09/20
- Novavax reports Q3 EPS ($3.21), may not compare to consensus $1.73
- 02/25/21
- Nielsen sees FY21 adjusted EPS $1.43-$1.54, consensus $1.66
- 02/25/21
- Nielsen reports Q4 adjusted EPS 53c, consensus 46c
- 02/24/21
- Notable companies reporting before tomorrow's open
- 03/01/21
- NIO sees Q1 revenue $1.13B-$1.16B, consensus $718.49M
- 03/01/21
- NIO reports Q4 adjusted EPS (14c), consensus (7c)
- 11/17/20
- NIO Inc. sees Q4 revenue $921.8M-$947.9M, consensus $805.66M
- 11/17/20
- NIO Inc. reports Q3 adj. EPS (12c), consensus (17c)
- 09/29/20
- Mereo BioPharma reports six months EPS (GBP1.05) vs. (22p) last year
- $84.57 /
+48.64 (+135.37%) - 03/01/21
- Morphic Holding reports 2020 EPS ($1.47), consensus ($1.41)
- 11/09/20
- Morphic Holding reports Q3 EPS 17c, consensus (48c)
- $1,715.90 /
+80.81 (+4.94%) - 03/01/21
- MercadoLibre reports Q4 EPS ($1.02), consensus 5c
- 11/04/20
- MercadoLibre reports Q3 EPS 28c, consensus 17c
- 03/01/21
- Lemonade sees FY21 revenue $114M-$117M, consensus $111.33M
- 03/01/21
- Lemonade sees Q1 revenue $21.5M-$22.5M, consensus $22.11M
- 03/01/21
- Lemonade reports Q4 EPS (60c), consensus (64c)
- 03/01/21
- Inseego reports Q4 EPS (14c), consensus 0c
- 11/05/20
- Inseego reports Q3 adjusted EPS 1c, consensus (1c)
- 03/01/21
- Inovio reports Q4 EPS (14c), consensus (22c)
- 11/09/20
- Inovio reports Q3 EPS 11c, consensus (19c)
- 03/01/21
- Helios Technologies reports Q4 EPS 60c, consensus 41c
- 11/02/20
- Helios Technologies sees FY20 revenue $485M-$495M, consensus $486.24M
- 11/02/20
- Helios Technologies reports Q3 adjusted EPS 53c, consensus 41c
- 03/01/21
- FibroGen reports Q4 EPS (64c), consensus (24c)
- 11/05/20
- FibroGen reports Q3 EPS 35c, consensus (80c)
- 02/11/21
- Cohu sees Q1 revenue $212M-$232M, consensus $207.9M
- 02/11/21
- Cohu reports Q4 non-GAAP EPS 73c, consensus 61c
- 12/01/20
- Cohu sees Q4 revenue $195M-$200M, consensus $186.26M
- 10/29/20
- Cohu sees Q4 revenue $176M-$192M, consensus $142.64M
- 02/25/21
- Beyond Meat reports Q4 adjusted EPS (34c), consensus (13c)
- 02/25/21
- Notable companies reporting after market close
- 11/09/20
- Beyond Meat reports Q3 adj. EPS (28c), consensus 5c
- 11/09/20
- Notable companies reporting after market close
ASLN Aslan Pharmaceuticals - 11/09/20
- Aslan Pharmaceuticals reports Q3 EPS (2c), two est. (9c)
- $160.72 /
-4.985 (-3.01%) - 03/01/21
- AppFolio reports Q4 EPS (1c), consensus 7c
- 11/09/20
- AppFolio reports Q3 EPS $3.86 vs. 14c last year
- 03/01/21
- Ameresco sees FY21 EPS $1.18-$1.26, consensus $1.22
- 03/01/21
- Ameresco reports Q4 EPS 47c, consensus 29c
- 11/02/20
- Ameresco raises FY20 adj. EPS view to 94c-$1.00 from 86c-96c
- 11/02/20
- Ameresco reports Q3 adjusted EPS 38c, consensus 25c
- 03/01/21
- C3.ai reports Q3 EPS (13c), consensus (16c)
- 02/16/21
- Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet
|
Periodicals
|
Amazon is being sued for… Amazon is being sued for "alleged race and gender discrimination, as well as pay equity violations," by a black senior manager, Charlotte Newman, wrote Laura Hautala for CNET. Newman, who works at Amazon Web Services, "alleges that she was assigned work consistent with employees in roles above the one she was hired and paid for," noted the CNET story. Newman alleged a " broader pattern of harassment of Black employees at the tech giant., in addition to being groped by "one former Amazon senior employee," says CNET. Reference Link ShowHide Related Items >><< - $3,146.17 /
+53.505 (+1.73%) - 03/01/21
- Amazon Prime Video, Eros STX Global confirm Nordics output deal
- 03/01/21
- Verizon, NFL, AWS leverage 5G, MEC for mobile gaming at Super Bowl LV
- 03/01/21
- President Biden tells Amazon not to meddle in union vote
- 02/24/21
- AWS announces general availability of Amazon Lookout for Vision
- $3,146.17 /
+53.505 (+1.73%) - 02/26/21 B. Riley Securities
- Plug Power recent selloff provides relative discount, says B. Riley
- 02/17/21 Needham
- Kornit Digital price target raised to $125 from $76 at Needham
- 02/17/21 Morgan Stanley
- Roku price target raised to $275 from $200 at Morgan Stanley
- 02/17/21 Citi
- Citi boosts target on favorite internet stock Amazon to $3,750
- $3,146.17 /
+53.505 (+1.73%) - 02/16/21
- Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet
- 02/02/21
- Amazon.com sees Q1 revenue $100B-$106B , consensus $95.69B
- 02/02/21
- Amazon.com reports Q4 EPS $14.09, consensus $7.23
- 02/02/21
- Notable companies reporting after market close
- $3,146.17 /
+53.505 (+1.73%) - 03/01/21
- Amazon Prime Video signs Nordics output deal with Eros STX Global, Variety says
- 03/01/21
- Amazon picks Nader Kabbani to lead vaccine rollout, BI reports
- 02/26/21
- Costco to hike minimum hourly wage to $16 an hour, WSJ reports
- 02/26/21
- Amazon's smart home boss to lead Fire TV, Appstore, Business Insider reports
- $3,146.17 /
+53.505 (+1.73%) - 03/01/21
- Fly Intel: What to watch in Target's earnings report
- 02/26/21
- Fly Intel: Wall Street's top stories at midday
- 02/17/21
- Under Armour downgrade, Amazon target raise among top calls on Wall Street
- 02/16/21
- Fly Intel: Wall Street's top stories for Tuesday
- $3,146.17 /
+53.505 (+1.73%) - 02/02/21
- Amazon options imply 7.6% move in share price post-earnings
- 12/31/20
- Unusually active option classes on open December 31st
- 12/29/20
- Unusually active option classes on open December 29th
- 10/26/20
- Early notable gainers among liquid option names on October 26th
|